Opaleye Management’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-258,556
| Closed | -$2.07M | – | 47 |
|
|
2021
Q3 | $2.07M | Buy |
258,556
+1,367
| +0.5% | +$11K | 0.39% | 38 |
|
|
2021
Q2 | $2.92M | Buy |
257,189
+153,589
| +148% | +$1.74M | 0.48% | 43 |
|
|
2021
Q1 | $958K | Buy |
+103,600
| New | +$958K | 0.14% | 56 |
|
|
2017
Q3 | – | Sell |
-10,857
| Closed | -$1.03M | – | 40 |
|
|
2017
Q2 | $1.03M | Sell |
10,857
-4,857
| -31% | -$459K | 0.43% | 39 |
|
|
2017
Q1 | $2.26M | Buy |
+15,714
| New | +$2.26M | 1.12% | 28 |
|